Network, engage and do business at Infosecurity Europe
Infosecurity Europe is the largest and most attended information security event in Europe. Held in central London, it is a free event featuring over 325 exhibitors presenting their most diverse range of new products and services. The free education programme attracts visitors from every segment of the industry across Europe.
From the New Exhibitor zone to the Country Pavilions, discover the latest products and solutions of the local and international scene. Attendees reflect every segment of the information security industry coming from key sectors including:
- IT distribution companies
- IT hardware, software, manufacturers and suppliers
- End-user information security professionals
- Government professionals.
The Infosecurity Europe Education programme provides a range of learning opportunities for its attendees where they can access high-level content through a host of different formats from panel discussions and presentations to workshops and training courses.
(ISC)2 and ISACA enable visitors of the free Education Programme to collect valuable CPD/CPE Credits, which get allocated automatically in the months after the event.
This year’s Keynote Theatre agenda will address the theme of security as a business enabler, focusing on how a proactive, resilient security strategy can add value to, and support growth and transformation in the hyper-connected business.
Bringing together senior end-user practitioners from the public and private sectors, policy-makers and analysts, the programme will provide strategic insight, best-practice and real-life experience, providing a opportunity for delegates to learn directly from the experts who are at the sharp-end of information security.
Supporting innovation and transformation
Information security is evolving, moving beyond technology to become a business discipline. By developing risk-based, intelligence lead security strategies, the information security function is able to determine what the real level of risk is to the business, and support decision-making within the organisation. To do this the information security function needs to shake off the reputation for being risk averse, stifling innovation, agility and efficiency with strict controls and policies to become business lead – sharing the risk appetite of the business whilst protecting the enterprise with business lead strategies. Delegates will learn how to develop and implement intelligence lead security strategies to add value to the business.
Future-proofing information security and protecting legacy systems
The pace of technological changes continues to increase. As businesses become more connected than ever before information security practitioners are tackling the dual challenges of securing current legacy systems that are increasingly vulnerable to new risks, whilst looking ahead at how to future-proof tomorrow’s legacy. At the show attendees will benefit from the opportunity to find out how to protect current legacy systems and build resilience in current technology to protect against future threats.
“Applification’ of business and implications for security
As applications increasingly become an essential part of a business, secure software development is critical to enable rapid adaption and speed to market. At the same time, “applification’ throws up a host of information security challenges. Embedding information security into software development is critical to minimise vulnerabilities and ensure software meets regulations and OWASP standards. At Infosecurity Europe 2014 attendees will discover how to embed security in the development lifecycle and how security and development can work together to achieve best practice and ensure the rapid delivery of secure applications to enable business growth securely.
Speakers already confirmed to speak in the Keynote Theatre at Infosecurity Europe include senior representatives from Skype, Pearson, Premier Farnell, Home Retail Group, Rank Group, Travis Perkins, Nike, BBC, National Crime Agency, HMRC, GE Capital and Amgen.